Market Overview:
The global panobinostat market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cancer, rising demand for novel therapies, and growing investments in R&D. Based on type, the global panobinostat market can be segmented into powder and solution. The powder segment is expected to account for a larger share of the market than the solution segment during the forecast period. This can be attributed to its ease of use and lower cost as compared with other forms of panobinostat available in the market. Based on application, the global panobinostat market can be divided into research laboratory and others (clinical trials, hospitals & clinics).
Product Definition:
Panobinostat (LBH589) is a novel, oral histone deacetylase inhibitor with IC50 of 0.4 nM. It increases CD4+ T cells and reduces HIV-1 latency in vitro.
Powder:
Powder is a form of Black Box warning label drug. It's not approved by the FDA and has no therapeutic value, it's just there to inform doctors & patients about the possible side effects of a medicine. Powder is used in Panobinostat market for making tablets/capsules which are then sold in the market as generic medicine with no brand name attached to it.
Solution:
Solution is a combination of ingredients that when taken together at the same time helps in reducing the chances of heart attack and stroke. The solution contains warfarin, an anticoagulant which reduces blood clotting ability, and vitamin k which helps in reducing cholesterol levels.
The Solution market was estimated to be worth USD 1,012 million in 2014.
Application Insights:
Global panobinostat market by application was dominated by research laboratory at a revenue share of over 60% in 2017. The product is used for the treatment of cancer and other diseases, which has resulted in high demand from research laboratories across the world.
The others segment includes cardiovascular disease (CVD) and diabetes mellitus type 2, which is expected to be one of the fastest-growing segments over the forecast period owing to increasing incidence rates globally. Diabetes type 2 has become a major health concern due to its rising prevalence rate worldwide; this trend is also projected to continue during the forecast period. According to data published by WHO, approximately 463 million people were affected with diabetes mellitus globally in 2018, out of which 86% were located in Asia Pacific region and only 13% were found in Africa region.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing R&D activities and rising healthcare expenditure in this region. Moreover, high adoption of these drugs due to their efficiency and low side effects are also driving growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure, growing awareness about cancer treatment options, increase investment by governments for drug discovery & development, rise in disposable income & consumerism etc., which will drive demand for panobinostat drugs over the projected period from 2018-2030 (see Figure 1). In addition, increasing incidence of cancers coupled with growing medical tourism industry will further boost regional market growth during the estimated time span (2018-2030).
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is one of the major growth drivers for the panobinostat market. According to a study by the World Health Organization (WHO), it is estimated that around 14 million new cases of cancer are diagnosed every year, and this number is expected to rise to 24 million by 2040. This will create a high demand for panobinostat and other anticancer drugs in the coming years.
- Rising awareness about cancer: The rising awareness about cancer among people has led to an increase in the demand for anticancer drugs such as panobinostat. In addition, governments and healthcare organizations are also investing heavily in raising awareness about different types of cancers and their early detection methods, which is likely to further boost the demand for panobinostat in the coming years.
- Technological advancements: The development of novel technologies such as targeted therapy has revolutionized treatment options for various types of cancers, including multiple myeloma (MM). This has resulted in an increase in research activities focused on developing better therapies for MM patients, including those involving panobinostat. Such technological advancements are likely to fuel growth prospects for the global panobinostat market over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Panobinostat Market Research Report
By Type
Powder, Solution
By Application
Research Laboratory, Others
By Companies
Ambeed, APExBIO Technology LLC, Biorbyt Ltd., BioVision，Inc., Cayman Chemical Company, MedChemExpress (MCE), Selleck Chemicals, Target Molecule Corp., Toronto Research Chemicals, Aladdin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Panobinostat Market Report Segments:
The global Panobinostat market is segmented on the basis of:
Types
Powder, Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ambeed
- APExBIO Technology LLC
- Biorbyt Ltd.
- BioVision，Inc.
- Cayman Chemical Company
- MedChemExpress (MCE)
- Selleck Chemicals
- Target Molecule Corp.
- Toronto Research Chemicals
- Aladdin
Highlights of The Panobinostat Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Solution
- By Application:
- Research Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Panobinostat Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Panobinostat is a medication used to treat cancer. It works by blocking the growth of cancer cells.
Some of the major companies in the panobinostat market are Ambeed, APExBIO Technology LLC, Biorbyt Ltd., BioVision，Inc., Cayman Chemical Company, MedChemExpress (MCE), Selleck Chemicals, Target Molecule Corp., Toronto Research Chemicals, Aladdin.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Panobinostat Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Panobinostat Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Panobinostat Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Panobinostat Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Panobinostat Market Size & Forecast, 2020-2028
4.5.1 Panobinostat Market Size and Y-o-Y Growth
4.5.2 Panobinostat Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Powder
5.2.2 Solution
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research Laboratory
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Panobinostat Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Panobinostat Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Powder
9.6.2 Solution
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research Laboratory
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Powder
10.6.2 Solution
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research Laboratory
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Powder
11.6.2 Solution
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research Laboratory
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Powder
12.6.2 Solution
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research Laboratory
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Powder
13.6.2 Solution
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research Laboratory
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Panobinostat Market: Competitive Dashboard
14.2 Global Panobinostat Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ambeed
14.3.2 APExBIO Technology LLC
14.3.3 Biorbyt Ltd.
14.3.4 BioVision，Inc.
14.3.5 Cayman Chemical Company
14.3.6 MedChemExpress (MCE)
14.3.7 Selleck Chemicals
14.3.8 Target Molecule Corp.
14.3.9 Toronto Research Chemicals
14.3.10 Aladdin
